HomeCompareZBH vs GWW

ZBH vs GWW: Dividend Comparison 2026

ZBH yields 1.08% · GWW yields 0.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GWW wins by $30.4K in total portfolio value
10 years
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →
GWW
GWW
● Live price
0.86%
Share price
$1,057.22
Annual div
$9.04
5Y div CAGR
54.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.7K
Annual income
$12,892.71
Full GWW calculator →

Portfolio growth — ZBH vs GWW

📍 GWW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZBHGWW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZBH + GWW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZBH pays
GWW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
GWW
Annual income on $10K today (after 15% tax)
$72.68/yr
After 10yr DRIP, annual income (after tax)
$10,958.80/yr
At 15% tax rate, GWW beats the other by $10,857.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZBH + GWW for your $10,000?

ZBH: 50%GWW: 50%
100% GWW50/50100% ZBH
Portfolio after 10yr
$36.5K
Annual income
$6,505.68/yr
Blended yield
17.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ZBH right now

ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
GWW
Analyst Ratings
10
Buy
23
Hold
4
Sell
Consensus: Hold
Price Target
$1,162.83
+10.0% upside vs current
Range: $1,044.00 — $1,300.00
Altman Z
9.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZBH buys
0
GWW buys
0
No recent congressional trades found for ZBH or GWW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZBHGWW
Forward yield1.08%0.86%
Annual dividend / share$0.96$9.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.2%54.3%
Portfolio after 10y$21.2K$51.7K
Annual income after 10y$118.64$12,892.71
Total dividends collected$1.1K$29.0K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusHoldHold
Analyst price target$105.60$1,162.83

Year-by-year: ZBH vs GWW ($10,000, DRIP)

YearZBH PortfolioZBH Income/yrGWW PortfolioGWW Income/yrGap
1← crossover$10,809$108.54$10,832$131.94$23.00GWW
2$11,675$109.86$11,796$206.09$121.00GWW
3$12,603$111.13$12,946$323.65$343.00GWW
4$13,598$112.34$14,364$512.20$766.00GWW
5$14,663$113.51$16,189$819.55$1.5KGWW
6$15,804$114.62$18,654$1,331.99$2.9KGWW
7$17,026$115.69$22,173$2,213.30$5.1KGWW
8$18,335$116.71$27,519$3,793.82$9.2KGWW
9$19,736$117.70$36,236$6,789.92$16.5KGWW
10$21,236$118.64$51,665$12,892.71$30.4KGWW

ZBH vs GWW: Complete Analysis 2026

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →

GWWIndustrials

W.W. Grainger, Inc. distributes maintenance, repair, and operating (MRO) products and services in the United States, Japan, Canada, the United Kingdom, and internationally. The company operates through two segments, High-Touch Solutions N.A. and Endless Assortment. It offers safety and security supplies, material handling and storage equipment, pumps and plumbing equipment, cleaning and maintenance supplies, and metalworking and hand tools. It also offers inventory management and technical support services. The company serves businesses, corporations, government entities, and other institutions through sales and service representatives, and electronic and ecommerce channels. W.W. Grainger, Inc. was founded in 1927 and is headquartered in Lake Forest, Illinois.

Full GWW Calculator →
📬

Get this ZBH vs GWW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZBH vs SCHDZBH vs JEPIZBH vs OZBH vs KOZBH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.